Downregulation of miR‐101 in gastric cancer correlates with cyclooxygenase‐2 overexpression and tumor growth

Authors:

Abstract
Cyclooxygenase‐2 (COX‐2) plays an important role in the carcinogenesis and progression of gastric cancer. It has been demonstrated thatCOX‐2 overexpression depends on different cellular pathways, involving both transcriptional and post‐transcriptional regulation. MicroRNAs (miRNAs) are small, noncodingRNAs that function as post‐transcriptional regulators. Here, we characterize miR‐101 expression and its role in the regulation ofCOX‐2 expression, which in turn, will provide us with additional insights into the potential therapeutic benefits of exogenous miR‐101 for treatment of gastric cancer. Our results showed that miR‐101 levels in gastric cancer tissues were significantly lower than those in the matched normal tissue (P < 0.01). Furthermore, lower levels of miR‐101 were associated with increased tumor invasion and lymph node metastasis (P < 0.05). We also found an inverse correlation between miR‐101 andCOX‐2 expression in both gastric cancer specimens and cell lines. Significant decreases inCOX‐2mRNAandCOX‐2 levels were observed in the pre‐miR‐101‐infected gastric cancer cells. One possible mechanism of interaction is that miR‐101 inhibitedCOX‐2 expression by directly binding to the 3′‐UTRofCOX‐2mRNA. Overexpression of miR‐101 in gastric cancer cell lines also inhibited cell proliferation and induced apoptosisin vitro, as well as inhibiting tumor growthin vivo. These results collectively indicate that miR‐101 may function as a tumor suppressor in gastric cancer, withCOX‐2as a direct target.

This publication has 39 references indexed in Scilit: